ArticleLeukemia research and treatment2017

Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation.

Morgan Belling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.